Bristol-Myers Squibb Company
- Targets
- 3
- Filings
- 5
- Median premium
- 53%
- First filing
- Feb 22, 2019
- Latest filing
- Feb 5, 2024
Targets
| Company | Score before deal | Score now | Filings | Latest |
|---|---|---|---|---|
| Karuna Therapeutics, Inc. | 2 / 7 | — | 2 | Feb 5, 2024 |
| Mirati Therapeutics, Inc. | 2 / 7 | — | 2 | Nov 2, 2023 |
| CELGENE CORP /DE/ | — | — | 1 | Feb 22, 2019 |